ID   DJM-1
AC   CVCL_1172
SY   DJM1
DR   CLO; CLO_0050680
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0375
DR   BioSample; SAMN03472223
DR   cancercelllines; CVCL_1172
DR   Cell_Model_Passport; SIDM00281
DR   ChEMBL-Cells; CHEMBL3308190
DR   ChEMBL-Targets; CHEMBL2366264
DR   Cosmic; 906841
DR   Cosmic-CLP; 906841
DR   DepMap; ACH-002100
DR   EGA; EGAS00001000978
DR   GDSC; 906841
DR   GEO; GSM1669733
DR   IARC_TP53; 21302
DR   LINCS_LDP; LCL-1405
DR   PharmacoDB; DJM1_292_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1172
DR   RCB; RCB0736
DR   Wikidata; Q54831104
RX   PubMed=1919059;
RX   PubMed=2439611;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Ser144Ter (c.431C>G); Zygosity=Homozygous (Cosmic-CLP; DepMap).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Heterozygous (Cosmic-CLP; DepMap).
CC   Omics: Deep exome analysis.
CC   Omics: Deep quantitative proteome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.62%; East Asian, South=19.44%; South Asian=0.93%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP; RCB
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 10,13
ST   D7S820: 7,8
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 33
//
RX   PubMed=1919059; DOI=10.1111/1523-1747.ep12491818;
RA   Katayama H., Kitagawa S., Masuyama J.-i., Yaoita H.;
RT   "Polymorphonuclear leukocyte-induced detachment of cultured epidermal
RT   carcinoma cells from the substratum.";
RL   J. Invest. Dermatol. 97:949-952(1991).
//
RX   PubMed=2439611; DOI=10.1111/1523-1747.ep12470554;
RA   Kitajima Y., Inoue S., Yaoita H.;
RT   "Effects of pemphigus antibody on the regeneration of cell-cell
RT   contact in keratinocyte cultures grown in low to normal Ca++
RT   concentration.";
RL   J. Invest. Dermatol. 89:167-171(1987).
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S.,
RA   Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P.,
RA   Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H.,
RA   Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010;
RA   Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N.,
RA   Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J.,
RA   Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L.,
RA   Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S.,
RA   Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B.,
RA   Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.;
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//